Lower Respiratory Disorders Flashcards
(35 cards)
Pulmonary Embolism (PE)
Emboli; mobile clots that travel through circulatory system
Blockage in a pulmonary artery by an embolic thrombus (fat or air embolus, or tissue from a tumor)
Travel to ever-smaller blood vessels until it lodges & obstructs perfusion of the alveoli
More than 90% arise from deep vein thrombosis (DVT) of the legs
Usually affects lower lobes d/t high volume of blood flow
10% of patients die within the first hour
Treatment with anticoagulants reduces mortality to less than 5%
PE Risk Factors
Immobility or reduced mobility
Surgery in the last 3 months
History of DVT
Malignancy
Obesity
Oral contraceptives & hormone therapy
Heavy cigarette smoking
Prolonged air travel
Heart failure
Pregnancy
Clotting disorders
PE Clinical Manifestations
Varied & nonspecific, making it difficulty to diagnose
Dyspnea
Hypoxemia (if severe, change in mental status)
Tachypnea
Cough
Chest pain
Hemoptysis
Crackles and/or wheezing
Tachycardia
Fever
Syncope
Massive PE = hypotension & shock
Complications
Pulmonary Infarction
Death of lung tissue
May become infected & abscess may develop
Pulmonary Hypertension
from a massive or recurrent PE
Results from hypoxemia or damage to 50% of area’s normal pulmonary bed
PE Diagnostic Studies
Find under-lying cause; DVT or AFIB?)
Spiral (helical) CT scan w/ IV contrast
Most frequently used to diagnose PE
Ventilation-perfusion (V/Q) lung scan
Used for those allergic to IV contrast
Mismatch of perfusion & ventilation indicates PE
EKG monitoring
Labs:
CBC
BMP
ABG’s
PTT
PT / INR
Troponin
D-dimer
Measures fibrin fragments
Not always accurate
Chest X-Ray
Venous ultrasound
Pulmonary angiography
PE Collaborative Care
Immediate treatment as soon as PE suspected
Bedrest; Semi-Fowler’s position
02 by NC or mask
Cardiac monitoring, VS, 02 level, ABG’s, breath sounds
Fibrinolytic agent
IV Heparin drip (RN management by protocol)
Lovenox (Low-molecular-weight Heparin)
Warfarin (Coumadin)
Monitor PTT and/or PT/INR levels
Opioids for pain relief
Medications PRN anxiety
Inferior Vena Cava filter
Inserted via femoral vein, placed at level of diaphragm
Pulmonary embolectomy
Patient Teaching
Risk factors
Long-term anticoagulant therapy
Frequent blood draws for PT/INR monitoring
Coumadin adjustments
Dietary considerations
Pneumonia
Acute infection of lung parenchyma
Gram-negative bacilli
8th leading cause of death in 2018
Impacted by discovery of Sulfa & Penicillin
Despite new anti-microbial agents, morbidity & mortality still significant
Risk Factors
Immunosuppressive diseases or debilitating illness
Increased risk of aspiration
Decreased cough & epiglottal reflexes, tube feedings
Impaired muco-ciliary mechanism
Pollution
Smoking
Upper respiratory infections
Tracheal intubation
Age >65 years
Malnutrition
Inhalation of microbes (Mycoplasma/fungus)
Spread from primary infection elsewhere in body
Opportunistic Pneumonia
Altered immune system
Severe protein-calorie malnutrition
HIV / AIDS
Radiation therapy
Chemotherapy
Long-term corticosteroid therapy
Pneumocystis jiroveci (fungus)– needs a human host
Cytomegalovirus (CMV)
Community-Acquired Pneumonia (CAP)
7th leading cause of death for those over 65 years old
Pre-hospital onset or within first 2-days of admit
Highest incidence in winter
Smoking important risk factor
May present only with dyspnea & fever while lung tissue is necrotized
Viral manifestations vary:
Fever, chills
Dry, non-productive cough
Extra-pulmonary symptoms
Hospital-Acquired Pneumonia (HAP)
48-hours or more after admission
Early (5-days or less post admission)
Late (more than 5-days post admission)
Nosocomial infection with highest mortality
Pseudomonas
Enterobacter
S. Aureus
S. Pneumoniae
Risk factors:
Immunosuppression
General debility
ET Tube (VAP)
Fungal/aspiration pneumonia
Loss of consciousness
Gag/cough reflexes
Tube feedings
CAP
Gradual symptom onset
Dry cough
Headache
Malaise / fatigue
Sore throat
N/V/D (S. aureus)
HAP
Sudden onset symptoms
Fever
Chills
Productive cough
Purulent sputum
Pleuritic chest pain
Confusion or stupor in older or debilitated patient
Clinical Manifestations CAP/HAP
Cough – non-productive or productive – green, yellow, bloody
Fever/chills/shaking
Dyspnea
Tachypnea
Pleuritic chest pain
May initially appear as influenza, then respiratory sypmtoms
Confusion or stupor r/t hypoxia
Hypothermia (in elderly)
Diaphoresis, anorexia, fatigue, myalgia, headache, abd pain
Rhonchi and Crackles
Dullness to percussion over affected area
Diagnostic Studies CAP/HAP
H & P
Chest X-Ray
Vital Signs - Sp02 and ABG’s
CBC, CMP, Blood Cultures
Sputum Culture – prior to Antibiotic therapy
Collaborative Therapy
CAP/HAP
Antibiotic therapy: Multi-drug resistant pneumonia is a major problem
Increased fluid intake (3L/day)
Limit activity and rest
Antipyretics
Analgesics
02 therapy
Influenza & Pneumonia Vaccination - pneumovax
Complications from Pneumonia
Pleurisy or pleural effusion
Atelectasis
Persistent infection
Lung abscess
Empyema
Pericarditis
Endocarditis
Arthritis
Meningitis
Pneumothorax
Sepsis
Respiratory failure
Nursing Assessment Pneumonia
History
Lung cancer
COPD
Diabetes mellitus
Debilitating disease
Malnutrition
AIDS
Use of antibiotics, corticosteroids, chemotherapy, immunosuppressants
Recent abdominal or thoracic surgery
Smoking, alcoholism, respiratory infections
Prolonged bed rest
Physical Assessment
Dyspnea
Nasal congestion
Pain with breathing
Sore throat
Muscle aches
Fever
Restlessness or lethargy
Splinting affected area
Tachypnea
Tachycardia
Asymmetric chest movements
Use of accessory muscles
Crackles
Green or yellow sputum
Nursing Considerations for Pneumonia
Tachycardia
Changes in mental status
Leukocytosis
Abnormal ABGs
Pleural effusion
Pneumothorax on x-ray
Pneumonia: Patient Teaching
Nutrition, hygiene, rest, regular exercise to maintain natural resistance
Prompt treatment of upper respiratory infections
Offer / encourage influenza & pneumococcal vaccines – New: COVID vaccine
Reposition every 2-hours
Assist with eating, drinking & taking medications
Emphasize need to finish course of antibiotics
Teach drug-drug interactions
TCDB / “Pulmonary toilet”
Strict asepsis, hand-washing
Lung Cancer Facts
Leading cause of cancer-related deaths in U.S.
Estimated 221,000 new cases diagnosed annually
High mortality, low cure rate – although treatment advancing
Early detection is important
Risk factors
Smoking – 80-90%
Pollution
Radiation
Occupational
Asbestos
Coal dust
Nickel
Uranium
Chromium
Formaldehyde
Arsenic
Types of Lung Cancer
Non-small cell (NSCLC) 80%
Squamous cell
Large bronchi
Slow speed- takes 8 to 10 yrs for a tumor to reach 1 cm
Adenocarcinoma
Alveoli
Moderate speed
Most common in nonsomokers
Large cell
Rapid speed
Highly metastatic
Small cell (SCLC) 20%
Larger airways
Most malignant
Early metastasis
Associated endocrine disorders
More sensitive to chemo
Poorer prognosis
Associated with paraneoplastic Syndrome
Diagnostic & Therapy
Chest X-Ray – 5% incidentally find cancer
Sputum cytology
Bronchoscopy
CT scan, MRI, PET, VATS,
Mediastinoscopy
Trans-bronchial or percutaneous fine-needle aspiration
Surgery
Radiation and/or Chemotherapy
Clinical Manifestations
Early
Persistent cough
Blood tinged sputum
Dyspnea or wheezing
Chest pain
Later
Anorexia
Fatigue
Weight loss
Nausea / vomiting
Hoarseness
Palpable lymph nodes in neck or axillae
Staging & Signs of Metastasis
Hoarseness
Recurrent laryngeal nerve
Dysphagia
Esophageal compression
Superior vena cava syndrome
Venous obstruction
Shortness of breath
Facial, arm, trunk swelling
Distended neck veins
Chest pain
Venous stasis
Mediastinal Lymph Node Involvement
Vocal cord paralysis
Dysphagia
Diaphragmatic paralysis
Phrenic nerve compression
Vena cava compression
Pleural effusion
Para-neoplastic Syndrome
Immune response against tumor mediated by humoral factors
Hormones & cytokines excreted by tumor cells
Hypercalcemia
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Dilutional hyponatremia
Anemia
Leukocytosis
Hypercoagulation disorders
Neurologic syndromes